An iatrogenic orphan?

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

In this issue of Blood, Wang and colleagues from the Mayo Clinic and the University of Iowa, describe the outcomes of patients diagnosed with diffuse large B-cell lymphoma (DLBCL) and treated in the era of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) who are also found to have an underlying indolent lymphoma in the lymph nodes or the bone marrow.

Original languageEnglish
Pages (from-to)1273-1274
Number of pages2
JournalBlood
Volume134
Issue number16
DOIs
StatePublished - Oct 17 2019

Fingerprint

Dive into the research topics of 'An iatrogenic orphan?'. Together they form a unique fingerprint.

Cite this